# AKTX (Akari Therapeutics, Plc) - SEC EDGAR Financial Statements

> Akari Therapeutics, Plc reported $36.58M in total assets and a net loss of $29.40M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/AKTX
- Markdown: https://convexityos.com/fundamentals/AKTX.md
- SEC CIK: 0001541157
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:04 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001541157&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$28.27M | Operating profit |
| Net Income | FY 2025 | -$29.40M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$0.00 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $5.74M | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $2.81M | $6.98M | $5.45M | $9.56M | $9.13M | $8.82M | $8.74M | $11.80M | $23.29M | $17.31M |
| Selling, General & Admin | $9.28M | $9.66M | $11.36M | $13.53M | $8.08M | $9.16M | $8.22M | $11.69M | $11.80M | $9.94M |
| Total Operating Expenses | $17.27M | $21.64M | $16.81M | $23.09M | $17.21M | $17.98M | $16.96M | $20.79M | $37.78M | $27.25M |
| **Operating Income** | -$17.27M | -$21.64M | -$16.81M | -$23.09M | -$17.21M | -$17.98M | -$16.96M | -$20.79M | -$37.78M | -$27.25M |
| **EBITDA** | -- | -$21.63M | -$16.80M | -$23.08M | -$17.21M | -$17.97M | -$16.94M | -$20.75M | -$37.74M | -$27.21M |
| Interest Income | $1.0K | $8.0K | $82K | $46K | $11K | $14K | $5.5K | $222K | $175K | $143K |
| Interest Expense | $100K | $244K | -- | -- | -- | -- | -- | -- | $0 | $0 |
| Income Before Tax | -$18.30M | -$19.79M | -$10.01M | -$18K | -$17.42M | -$17.08M | -$16.85M | -$20.50M | -$35.40M | -$18.14M |
| Income Tax Expense | -$1.00M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$17.30M | -$19.79M | -$10.01M | -$17.75M | -$17.42M | -$17.08M | -$16.85M | -$20.50M | -$35.40M | -$18.14M |
| Basic EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$0.01 | -$0.01 | -$0.01 | -$0.03 | -$0.02 |
| **Diluted EPS** | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$0.01 | -$0.01 | -$0.01 | -$0.03 | -$0.02 |
| Basic Shares Outstanding | 67.33B | 23.89B | 9.79B | 6.24B | 4.29B | 3.16B | 1.83B | 1.54B | 1.25B | 1.18B |
| Diluted Shares Outstanding | 67.33B | 23.89B | 9.79B | 6.24B | 4.29B | 3.16B | 1.83B | 1.54B | 1.25B | 1.18B |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $2.11M | $2.08M | $1.46M | $1.09M | $249K | $667K | $813K | $1.25M |
| Selling, General & Admin | $2.57M | $2.52M | $2.17M | $2.14M | $1.98M | $2.45M | $2.71M | $3.05M |
| Total Operating Expenses | -- | -- | $15.76M | -- | -- | -- | $3.52M | -- |
| **Operating Income** | -$4.68M | -$4.60M | -$15.76M | -$3.23M | -$7.40M | -$3.12M | -$3.52M | -$5.28M |
| **EBITDA** | -- | -- | -- | -- | -- | -- | -- | -$5.28M |
| Interest Income | -- | -- | -- | -- | $1.0K | -- | -- | $1.0K |
| Interest Expense | $85K | $80K | $61K | $723K | $100K | $50K | $55K | -- |
| Income Before Tax | -$4.84M | -$4.81M | -$15.31M | -$5.21M | -$7.49M | -$1.90M | -$3.71M | -- |
| Income Tax Expense | $0 | $0 | -$859K | $85K | -$1.09M | $0 | $0 | -- |
| **Net Income** | -$4.84M | -$4.81M | -$14.46M | -$5.30M | -$6.40M | -$1.90M | -$3.71M | -$3.77M |
| Basic EPS | $0.00 | $0.00 | $0.00 | -- | $0.00 | $0.00 | $0.00 | -- |
| **Diluted EPS** | $0.00 | $0.00 | $0.00 | -- | $0.00 | $0.00 | $0.00 | -- |
| Basic Shares Outstanding | 265.89B | 143.32B | 118.76B | -- | 65.33B | 62.94B | 54.59B | -- |
| Diluted Shares Outstanding | 265.89B | 143.32B | 118.76B | -- | 65.33B | 62.94B | 54.59B | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2020 | FY 2020 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $5.20M | $0 | $3.85M | $13.25M | $9.36M | $14.06M | $12.32M | $12.75M | $7.82M | $5.73M |
| **Cash & Short-Term Investments** | $5.20M | $0 | $3.85M | $13.25M | $9.36M | $14.06M | $12.32M | $12.75M | $7.82M | $5.73M |
| Other Current Assets | $14K | $201K | $197K | $100K | $90K | $229K | -- | -- | -- | -- |
| **Total Current Assets** | $5.46M | $2.95M | $4.34M | $13.81M | $11.63M | $14.58M | $13.67M | $14.43M | $9.65M | $6.44M |
| Property, Plant & Equipment, Net | -- | -- | -- | $0 | $0 | $0 | -- | -- | $2.1K | $5.0K |
| Goodwill | $8.43M | $8.43M | -- | -- | -- | -- | -- | -- | -- | -- |
| Intangible Assets | -- | -- | $14K | $17K | $23K | $27K | $27K | $26K | $28K | $30K |
| **Total Non-Current Assets** | $42.43M | $47.61M | $14K | $17K | $23K | $27K | $27K | $26K | $30K | $35K |
| **Total Assets** | $47.89M | $50.56M | $4.36M | $13.83M | $11.65M | $14.60M | $13.69M | $14.45M | $9.68M | $6.48M |
| Accounts Payable | $8.77M | $12.41M | $1.67M | $947K | $1.79M | $3.38M | $2.41M | $2.19M | $966K | $1.23M |
| Other Current Liabilities | $424K | $94K | $94K | $94K | $0 | -- | -- | -- | -- | -- |
| **Total Current Liabilities** | $12.35M | $19.91M | $4.58M | -- | -- | -- | -- | -- | -- | -- |
| Other Non-Current Liabilities | $31K | $383K | -- | -- | -- | -- | -- | -- | -- | -- |
| **Total Non-Current Liabilities** | $7.21M | $8.42M | $0 | -- | -- | -- | -- | -- | -- | -- |
| **Total Liabilities** | $19.56M | $28.33M | $4.58M | $12.04M | $6.09M | $5.22M | $6.75M | $8.49M | $6.41M | $6.47M |
| Common Stock | -- | $5.32M | $1.32M | $745K | $476K | $385K | $46.58M | $46.58M | $40.09M | $31.99M |
| Retained Earnings | -$264.6M | -$247.3M | -$227.5M | -$217.5M | -$199.7M | -$182.3M | -$175.5M | -$176.4M | -$168.9M | -$165.2M |
| Accumulated Other Comp. Income | -$782K | -$738K | -$1.04M | -$771K | -$541K | -$648K | -$621K | -$618K | -$572K | -$349K |
| **Total Stockholders' Equity** | $28.33M | $22.23M | -$229K | $1.79M | $5.55M | $9.38M | $6.95M | $5.96M | $3.27M | $7.6K |
| Total Equity | $28.33M | $22.23M | -$229K | $1.79M | $5.55M | $9.38M | $6.95M | $5.96M | $3.27M | $7.6K |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $5.74M | $7.69M | $2.77M | $5.20M | $2.48M | $2.71M | $2.58M | $0 |
| **Cash & Short-Term Investments** | $5.74M | $7.69M | $2.77M | $5.20M | $2.48M | $2.71M | $2.58M | $0 |
| Other Current Assets | $107K | $38K | $30K | $14K | $53K | $83K | $80K | $201K |
| **Total Current Assets** | $6.28M | $8.32M | $3.59M | $5.46M | $2.95M | $3.30M | $3.35M | $2.95M |
| Goodwill | -- | -- | -- | $8.43M | $8.43M | $8.43M | $8.43M | $8.43M |
| **Total Non-Current Assets** | $30.30M | $30.30M | $30.30M | $42.43M | $42.43M | $47.61M | $47.61M | $47.61M |
| **Total Assets** | $36.58M | $38.62M | $33.89M | $47.89M | $45.38M | $50.91M | $50.96M | $50.56M |
| Accounts Payable | $9.05M | $9.40M | $8.64M | $8.77M | $10.84M | $11.61M | $13.07M | $12.41M |
| Other Current Liabilities | $54K | $212K | $697K | $424K | $481K | $650K | $484K | $94K |
| **Total Current Liabilities** | $12.98M | $13.94M | $13.41M | $12.35M | $15.57M | $17.14M | $20.91M | $19.91M |
| Other Non-Current Liabilities | -- | -- | -- | $31K | $69K | $128K | $266K | $383K |
| **Total Non-Current Liabilities** | $6.09M | $6.09M | $6.09M | $7.21M | $7.12M | $8.17M | $8.31M | $8.42M |
| **Total Liabilities** | $19.08M | $20.03M | $19.51M | $19.56M | $22.69M | $25.31M | $29.21M | $28.33M |
| Common Stock | $1.0K | $1.0K | -- | -- | $6.52M | $6.52M | $5.78M | $5.32M |
| Retained Earnings | -$288.7M | -$283.8M | -$279.0M | -$264.6M | -$259.3M | -$252.9M | -$251.0M | -$247.3M |
| Accumulated Other Comp. Income | -$614K | -$695K | -$768K | -$782K | -$1.14M | -$1.11M | -$773K | -$738K |
| **Total Stockholders' Equity** | $17.50M | $18.59M | $14.38M | $28.33M | $22.69M | $25.61M | $21.75M | $22.23M |
| Total Equity | $17.50M | $18.59M | $14.38M | $28.33M | $22.69M | $25.61M | $21.75M | $22.23M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$17.30M | -$19.79M | -$10.01M | -$17.75M | -$17.42M | -$17.08M | -$16.85M | -$20.50M | -$35.40M | -$18.14M |
| Depreciation & Amortization | -- | $14K | $4.0K | $4.0K | $4.1K | $8.9K | $19K | $36K | $42K | $40K |
| Stock-Based Compensation | $2.89M | $2.25M | $1.15M | $735K | $315K | $326K | $1.05M | $1.65M | $2.73M | $3.93M |
| **Operating Cash Flow** | -$10.57M | -$12.55M | -$16.43M | -$21.50M | -$18.85M | -$16.95M | -$12.92M | -$22.77M | -$31.60M | -$24.62M |
| Capital Expenditure | -- | -- | -- | -- | -- | -- | $0 | $0 | -$37K | -$55K |
| **Free Cash Flow** | -- | -- | -- | -- | -- | -- | -$12.92M | -$22.77M | -$31.64M | -$24.68M |
| **Investing Cash Flow** | -- | $382K | -- | -- | -- | -- | $0 | $0 | $9.99M | -$10.07M |
| Common Stock Issued | $10.72M | $11.81M | $7.02M | $25.19M | $14.29M | $25.05M | $12.65M | $500K | $15.67M | $0 |
| **Financing Cash Flow** | $13.17M | $10.99M | $7.02M | $25.29M | $14.29M | $25.07M | $12.65M | $500K | $15.67M | $0 |
| **Net Change in Cash** | $2.60M | -$1.19M | -$9.40M | $3.89M | -$4.69M | $8.32M | -$236K | -$22.28M | -$5.99M | -$34.82M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$4.84M | -$4.81M | -$14.46M | -$5.30M | -$6.40M | -$1.90M | -$3.71M | -$3.77M |
| Depreciation & Amortization | -- | -- | -- | -- | -- | -- | -- | $1.0K |
| Stock-Based Compensation | $537K | $711K | $305K | $471K | $685K | $719K | $1.01M | $1.26M |
| **Operating Cash Flow** | -$4.22M | -$3.11M | -$2.49M | -$3.04M | -$2.12M | -$3.26M | -$2.15M | -$2.12M |
| Common Stock Issued | -- | -- | -- | $4.85M | $0 | $4.79M | $1.09M | $3.13M |
| **Financing Cash Flow** | $2.27M | $8.04M | $53K | $5.76M | $1.90M | $3.38M | $2.13M | $2.15M |
| **Net Change in Cash** | -$1.95M | $4.93M | -$2.44M | $2.72M | -$227K | $129K | -$17K | $413K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -61.1% | -89.0% | -- | -991.0% | -313.7% | -182.0% | -221718.9% | -469.2% | -159.2% | -53.2% |
| Return on Assets (ROA) | -36.1% | -39.1% | -229.8% | -128.3% | -149.6% | -117.0% | -260.0% | -255.3% | -121.9% | -39.5% |
| Current Ratio | 0.44x | 0.15x | 0.95x | -- | -- | -- | -- | 1.52x | 2.43x | 3.90x |
| Quick Ratio | 0.42x | 0.00x | 0.84x | -- | -- | -- | -- | 1.11x | 2.37x | 3.77x |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -168.0% | -166.5% | -195.0% | -61.1% | -69.5% | -47.9% | -82.5% | -89.0% |
| Return on Assets (ROA) | -80.4% | -80.2% | -82.8% | -36.1% | -34.8% | -24.1% | -35.2% | -39.1% |
| Current Ratio | 0.48x | 0.60x | 0.27x | 0.44x | 0.19x | 0.19x | 0.16x | 0.15x |
| Quick Ratio | 0.44x | 0.55x | 0.21x | 0.42x | 0.16x | 0.16x | 0.12x | 0.00x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
